Biblio Discovery — Demo Discovery Service

3 hasil untuk "Alessandro Conti"

Menampilkan 1–3 · 0,32 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Assessing the relationship between toxicity and economic cost of oncological target agents: A systematic review of clinical trials

    Francesca Tartari; Alessandro Conti; Roy Cerqueti

    PLOS ONE, Vol. 12 No. 8 · 2017 · Inggris · PLOS Scopus

    Target agents are peculiar oncological drugs which differ from the traditional therapies in their ability of recognizing specific molecules expressed by tumor cells and microenvironment. Thus, their toxicity is generally lower than that associated to chemotherapy, and they represent nowadays a new…

  2. Artikel Jurnal Teks lengkap

    The Changes of Lipid Metabolism in Advanced Renal Cell Carcinoma Patients Treated with Everolimus: A New Pharmacodynamic Marker?

    Francesco Pantano; Matteo Santoni; Giuseppe Procopio dkk.

    PLOS ONE, Vol. 10 No. 4 · 2015 · Inggris · PLOS Scopus

    Background: Everolimus is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment of metastatic renal cell carcinoma (mRCC). We aimed to assess the association between the baseline values and treatmentrelated modifications of total serum cholesterol (C), triglycerides (T), body…

  3. Artikel Jurnal Teks lengkap

    Natural History of Malignant Bone Disease in Hepatocellular Carcinoma: Final Results of a Multicenter Bone Metastasis Survey

    Daniele Santini; Francesco Pantano; Ferdinando Riccardi dkk.

    PLoS ONE, Vol. 9 No. 8 · 2014 · Inggris · PLOS Scopus

    Background: Bone is an uncommon site of metastasis in patients with advanced hepatocellular carcinoma (HCC). Therefore, there are few studies concerning the natural history of bone metastasis in patients with HCC. Patients and Methods: Data on clinicopathology, survival, skeletal-related events…